Medicenna Therapeutics Corp. - COM (MDNAF)

CUSIP: 58490H107

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / COM
Total 13F shares
1,755,051
Share change
+1,700,151
Total reported value
$7,237,374
Price per share
$4.14
Number of holders
13
Value change
+$7,009,822
Number of buys
13

Quarterly Holders Quick Answers

What is CUSIP 58490H107?
CUSIP 58490H107 identifies MDNAF - Medicenna Therapeutics Corp. - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Medicenna Therapeutics Corp. - COM (MDNAF) as of Q3 2020

As of 30 Sep 2020, Medicenna Therapeutics Corp. - COM (MDNAF) was held by 13 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,755,051 shares. The largest 10 holders included AWM Investment Company, Inc., Soleus Capital Management, L.P., RENAISSANCE TECHNOLOGIES LLC, VR Adviser, LLC, TOCQUEVILLE ASSET MANAGEMENT L.P., Rathbone Brothers plc, Creative Planning, JPMORGAN CHASE & CO, Patriot Financial Group Insurance Agency, LLC, and Federation des caisses Desjardins du Quebec. This page lists 13 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.